Pembrolizumab plus ipilimumab for advanced melanoma

results of the keynote-029 expansion cohort

G. Long, V. Atkinson, Jonathan S. Cebon, M. B. Jameson, B. M. Fitzharris, C. M. McNeil, A. G. Hill, A. Ribas, Michael B. Atkins, J. A. Thompson, W-J Hwu, F. S. Hodi, A. M. Menzies, A. D. Guminski, R. Kefford, Xu Jie Shu, S. Ebbinghaus, N. Ibrahim, M. Carlino

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)60-61
Number of pages2
JournalAsia-Pacific Journal of Clinical Oncology
Volume12
Issue numberS4
Publication statusPublished - Aug 2016

Cite this

Long, G., Atkinson, V., Cebon, J. S., Jameson, M. B., Fitzharris, B. M., McNeil, C. M., ... Carlino, M. (2016). Pembrolizumab plus ipilimumab for advanced melanoma: results of the keynote-029 expansion cohort. Asia-Pacific Journal of Clinical Oncology, 12(S4), 60-61.